Acutus Medical to Present at the 43rd Annual Canaccord Growth Conference
CARLSBAD, Calif., July 27, 2023 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will present at the 43rd Annual Canaccord Growth Conference on Thursday, August 10, 2023 at 9:30 a.m. Eastern Time at the InterContinental Boston Hotel in Boston, MA.
Related news for (AFIB)
- Acutus Medical Reports Full Year 2024 Financial Results
- Acutus Medical Announces Operational Downsizing
- Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results
- Acutus Medical Reports Second Quarter and Year-To-Date 2024 Financial Results
- Acutus Medical Reports First Quarter 2024 Financial Results